Pharmaceutical

Eli Lilly overtakes Tesla in market value

Eli Lilly is now worth about $600 billion, eclipsing Tesla, which has fallen abo...

STAT+: Pharmalittle: We’re reading about Sanders jabbin...

U.S. Sen. Bernie Sanders jabbed Merck CEO Robert Davis for telling congressional...

A call to add sexual orientation and gender identity da...

"How can I even do routine preventative health care maintenance for LGBTQ+ adult...

Opinion: Congress must pass the child tax credit deal t...

Congress must pass the child tax credit deal to support kids’ health.

Harnessing the untapped potential of medicines access 

We speak with BAP Pharma to learn more about the challenges and possible benefit...

Evaxion Biotech to develop new vaccines for cancer

Evaxion Biotech has announced plans to develop customised cancer vaccines by tar...

Kyowa Kirin acquires Orchard Therapeutics for $477.6m

Kyowa Kirin has acquired Orchard Therapeutics, a developer of hematopoietic stem...

Synnovation launches with $102m to advance therapy pipe...

Synnovation Therapeutics has launched with a $102m Series A financing to progres...

FDA denies approval for Theratechnologies’ tesamorelin F8

Theratechnologies has received a CRL from the US Food and Drug Administration (F...

PXS-4728 by Syntara for Sleep Disorders: Likelihood of ...

PXS-4728 is under clinical development by Syntara and currently in Phase II for ...

Lava signs collaboration agreement with MSD for prostat...

MSD will supply Keytruda to be evaluated as a combination treatment with Lava’s ...

Repare bags $40m from Roche as solid tumour trial begins

The milestone-based payment came from Roche after Repare dosed the first patient...

Gilead’s Tecartus escapes harsher classwide boxed warni...

The US FDA has requested a different safety label for Gilead’s Tecartus compared...

What is the UK’s Covid-19 drug armoury like amid rising...

As a new variant spearheads a winter spike in Covid-19 infections in the UK, the...

STAT+: Sanofi scoops up U.S. biotech Inhibrx for up to ...

As it expands its pipeline of inflammation-targeting drugs, Sanofi said Tuesday ...

STAT+: When it comes to policing pharma, the FTC says i...

The FTC has attempted to crack down on the pharma industry over concerns that dr...